FindTrial
Sign In

Effect of Basti (Panchakarma) in Heart Disorders

Evaluation of Punarnavadi Basti In Management of Coronary Artery Disease (Hridroga) - An Open Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028610
Enrollment
10
Registered
2020-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I209- Angina pectoris, unspecified

Interventions

Intervention1: PUNARNAVADI BASTI: Punarnavadi basti (Niruha basti), Dose - 630 ml Dashamooladi taila (Anuvasana basti) Dose- 60ml Punarnavadi basti Quantity Madhu 80 ml Guda 40

Sponsors

Dr LINGAMPALLI RAKESH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Symptoms of CAD (Exertional Dyspnoea, Chest Pain Chest Tightness, chest heaviness Diagnostic case of CAD or Known case of CAD Age between 30-70 years Either sex Fit for Basti

Exclusion criteria

Exclusion criteria: CAD with Cardio Myopathy CAD with Valvular Heart defect Congestive Cardiac Failure

Design outcomes

Primary

MeasureTime frame
Punarnavadi basti is efficacious in treating signs & symptoms of Coronary artery disease more efficiently.Timepoint: Baseline 11th Day 33rd Day—

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE—

Countries

India

Contacts

Public ContactDR RAJASHEKHAR V SANAPETI

KAHERs Shri B.M.Kankanwadi Ayurveda Mahavidyalaya,

rajashekharpk@gmail.com9611442881

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026